Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
Szilárd Kiss,1 Hitesh S Chandwani,2 Ashley L Cole,2 Vaishali D Patel,2 Orsolya E Lunacsek,3 Pravin U Dugel4 1Department of Ophthalmology, Weill Cornell Medical College, New York, NY, 2Global Health Economics and Outcomes Research, Allergan, Inc., Irvine, CA, 3Global Health Economics and...
Guardado en:
Autores principales: | Kiss S, Chandwani HS, Cole AL, Patel VD, Lunacsek OE, Dugel PU |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e1c11b834e34c69aeb3400f3071287b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Javier Obis, et al.
Publicado: (2021) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski A, et al.
Publicado: (2016) -
Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper JM, et al.
Publicado: (2018) -
Long-term outcomes of intended undercorrection intraocular lens implantation in pediatric cataract
por: Lekskul A, et al.
Publicado: (2018) -
Assessment of Post-Operative Pseudophakic Glaucoma by Ultrasound Biomicroscopy
por: Ragab IT, et al.
Publicado: (2020)